This trial is comparing two types of MRI scans to see if one is better than the other at detecting prostate cancer.
- Prostate Cancer
1 Primary · 7 Secondary · Reporting Duration: At an expected average of 30 days post-intervention
2 Treatment Groups
1 of 2
1 of 2
500 Total Participants · 2 Treatment Groups
Primary Treatment: Biparametric MRI +/- prostate biopsy · No Placebo Group · N/A
Who is running the clinical trial?
Age 18+ · Male Participants · 4 Total Inclusion CriteriaMark “Yes” if the following statements are true for you:
Frequently Asked Questions
What is the current enrollment cap of this clinical trial?
"To complete this study, 500 qualified participants must be enrolled. Potential enrollees can visit one of the many trial sites such as Jewish General Hospital in Montréal and University of Chicago located in Minnesota." - Anonymous Online Contributor
Are there any Canadian facilities currently undertaking this research initiative?
"8 medical centres across North America are hosting this clinical trial. Participants will be able to find one close by, as the sites span Montréal, Chicago and New York along with 8 other cities. This should reduce travel needs for those who choose to join the study." - Anonymous Online Contributor
Is enrollment for the clinical trial still available?
"Clinicaltrials.gov states that this research is still recruiting participants, with the initial posting occuring on April 5th 2022 and last update occurring on May 11th of the same year." - Anonymous Online Contributor